Alcon AG | ALC - Operating Expenses


Alcon AG reported $2.41B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
AstraZeneca USD 12.53B 4.16B Dec/2025
Bayer EUR 10.33B 126M Dec/2025
Essilor EUR 13.09B 1.07B Dec/2025
Fresenius EUR 5.25B 337M Dec/2025
Fresenius Medical Care EUR 4.41B 27.91M Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GRIFOLS EUR 1.71B 193M Dec/2025
Lonza CHF 2.9B 184M Jun/2025
Merck EUR 4.78B 669M Dec/2025
Novartis USD 9.8B 61M Dec/2025
Philips EUR 4.38B 405M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Smith & Nephew USD 2.52B 84M Dec/2025
Sonova Holding CHF 1.52B 59.9M Dec/2025
UCB EUR 2.96B 196M Dec/2025